Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

MENT: summary of concept data and preclinical and clinical results

Feb. 9, 1998

Controlled-release melatonin for treating sleep disorders in the elderly

Feb. 9, 1998

Estrogen replacement also a possibility in men?

Feb. 9, 1998

Nitric oxide as a target in stroke therapy

Feb. 6, 1998

Promising laboratory findings and phase I results reported for Leukine

Feb. 6, 1998

Glaxo Wellcome's new NRTI highlighted at AIDS conference

Feb. 6, 1998

FddA demonstrates anti-HIV activity at well-tolerated doses in phase I trial

Feb. 5, 1998

Pharmacokinetics and drug interactions for Fortovase

Feb. 5, 1998

NIF is neuroprotective in rat model of ischemia

Feb. 5, 1998

PNU-140690: clinical pharmacokinetics and safety after single and multiple doses

Feb. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...